Comparison of the behavioral effects of ibogaine from three sources: mediation of discriminative activity

This publication has 17 references indexed in Scilit:

• Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies
  Brain Research, 1992
• Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis study
  European Journal of Pharmacology, 1991
• Effects and aftereffects of ibogaine on morphine self-administration in rats
  European Journal of Pharmacology, 1991
• Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”)
  Pharmacology Biochemistry and Behavior, 1988
• Dopamine neurochemical profile of atypical antipsychotics resembles that of D-1 antagonists
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1988
• Central serotonin receptors as targets for drug research
  Journal of Medicinal Chemistry, 1987
• CGS 10746B: An atypical antipsychotic candidate that selectively decreases dopamine release at behaviorally effective doses
  Life Sciences, 1986
• Discriminative profile of MDMA
  Pharmacology Biochemistry and Behavior, 1986
• Speculations on the mechanism of action of hallucinogenic indolealkylamines
  Neuroscience & Biobehavioral Reviews, 1981
• FENFLURAMINE AND BRAIN SEROTONIN
  Annals of the New York Academy of Sciences, 1978